Follow the 皓元医药 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 皓元医药 has logged 9 reports. Market capitalisation: €17.1bn. The latest transaction was reported on 25 June 2026 (Sale). Among the most active insiders: 李硕梁. Every trade is openly available.
9
Insider Decl.
n/a
Thresholds
€109,271
1 ops.
Buy Volume
€789,452
8 ops.
Sell Volume
5Σ signal
Buys €109,271€789,452 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,797 of 29,063 companies
39.8
score / 100
Value
28
Quality
51
FCF yld0.5%
Earn yld1.2%
EV/EBITDA44.3x
ROE7.5%
Gross mgn47%
Net mgn8.3%
Debt/EBITDA4.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.